Learning Objectives:
1) To understand who are the appropriate patients to receive anti-amyloid antibodies;
2) to understand the benefits of anti-amyloid therapy; and
3) to appreciate the risks involved with anti-amyloid therapy
Session date:
10/25/2024 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Dr. David Knopman